API Particle Size Risks During Lab-to-Pilot Scale-Up
Mitigating API Particle Size Risks When Scaling from Lab to Pilot Scaling from lab to pilot scale presents a variety of challenges, notably the risks associated with active pharmaceutical ingredient…